α/β-Hydrolase Domain (ABHD) Inhibitors as New Potential Therapeutic Options against Lipid-Related Diseases

[Image: see text] Much of the experimental evidence in the literature has linked altered lipid metabolism to severe diseases such as cancer, obesity, cardiovascular pathologies, diabetes, and neurodegenerative diseases. Therefore, targeting key effectors of the dysregulated lipid metabolism may repr...

Descripción completa

Detalles Bibliográficos
Autores principales: Bononi, Giulia, Tuccinardi, Tiziano, Rizzolio, Flavio, Granchi, Carlotta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389839/
https://www.ncbi.nlm.nih.gov/pubmed/34213320
http://dx.doi.org/10.1021/acs.jmedchem.1c00624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389839/
https://www.ncbi.nlm.nih.gov/pubmed/34213320
http://dx.doi.org/10.1021/acs.jmedchem.1c00624

Ejemplares similares